Thorne HealthTech, Inc.
NASDAQ:THRN
10.19 (USD) • At close October 13, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||||||||
Net Income
| 4.332 | -0.531 | 12.402 | 3.587 | -5.767 | 4.711 | 1.521 | 0.951 | -0.333 | 4.706 | -1.79 | 4.161 | -5.148 | -1.177 |
Depreciation & Amortization
| 1.69 | 1.561 | 1.385 | 1.573 | 1.524 | 1.342 | 1.124 | 1.067 | 1.277 | 0.985 | 1.445 | 0.958 | 0.947 | 0.947 |
Deferred Income Tax
| 0.13 | 0 | -7.782 | 680.363 | 0 | 0.086 | -0.743 | -1.953 | 4.403 | 1.581 | 1.658 | 1.01 | 0.34 | 0.707 |
Stock Based Compensation
| 2.873 | 3.748 | 2.929 | 3.255 | 3.142 | 2.009 | 3.129 | 0.891 | 0.024 | 0.511 | 0.241 | 1.396 | 5.327 | 3.073 |
Change In Working Capital
| 5.052 | -11.946 | 5.805 | -11.414 | -0.856 | -14.224 | -3.152 | 2.355 | -14.94 | -0.447 | 2.428 | -3.184 | 0.074 | -1.578 |
Accounts Receivables
| -6.393 | -4.508 | -0.759 | -3.035 | -1.141 | -3.867 | 0.41 | 0.31 | -1.688 | -1.919 | 5.896 | -3.83 | 1.889 | -1.348 |
Change In Inventory
| -11.13 | -2.107 | 3.308 | -0.74 | -9.897 | -9.424 | -3.147 | 1.679 | -7.862 | -3.549 | -0.948 | 2.771 | -2.808 | 0.276 |
Change In Accounts Payables
| 21.453 | -2.401 | 1.569 | -7.06 | 7.518 | 2.405 | -2.012 | 4.508 | -3.405 | 7.11 | -0.899 | -1.172 | 2 | 1.132 |
Other Working Capital
| 1.122 | -2.931 | 1.688 | -0.579 | 2.663 | -3.338 | 3.195 | -8.283 | -3.971 | -4.176 | -3.241 | -1.908 | -2.013 | -3.275 |
Other Non Cash Items
| 0.935 | 1.443 | -0.716 | -679.157 | -0.549 | 1.574 | 0.323 | -0.01 | 6.072 | 3.031 | 3.104 | 2.423 | 1.739 | 1.721 |
Operating Cash Flow
| 15.012 | -5.726 | 14.023 | -1.793 | -2.507 | -4.501 | 2.944 | 5.254 | -7.901 | 8.787 | 5.428 | 5.753 | 2.94 | 2.986 |
Investing Activities: | ||||||||||||||
Investments In Property Plant And Equipment
| -8.063 | -13.361 | -12.066 | -3.195 | -0.734 | -1.868 | -2.374 | -0.987 | -1.111 | -0.589 | -0.923 | -0.321 | -0.607 | -0.471 |
Acquisitions Net
| 0 | -4 | 0 | 0 | -14.846 | -15.862 | -0.705 | 0 | 0 | 0 | -0.215 | 0 | 0 | 0 |
Purchases Of Investments
| 0 | 0 | 1 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 0 | 0 | -0.901 | 0 | 15.846 | 0 | -0.187 | 0.001 | -1.976 | 0 | -0.829 | 1.864 | -3.214 | -0.1 |
Investing Cash Flow
| -8.063 | -17.361 | -11.967 | -3.195 | -0.734 | -17.73 | -3.079 | -0.987 | -2.524 | -0.589 | -1.138 | 1.643 | -3.721 | -0.471 |
Financing Activities: | ||||||||||||||
Debt Repayment
| -10.985 | -15.95 | -1.102 | -0.228 | -0.226 | -0.227 | -20.663 | -0.255 | -0.199 | -0.126 | -0.961 | -3.35 | -0.996 | -13.9 |
Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| -0.824 | -0.403 | -0.968 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.267 |
Other Financing Activities
| 5.565 | 30.161 | 13.226 | 0.06 | -0.006 | 2.826 | 0.108 | 62.959 | -2.991 | 0 | 0 | -0.153 | 0.091 | 20 |
Financing Cash Flow
| -6.244 | 13.808 | 11.157 | -0.168 | -0.232 | 2.599 | -20.555 | 62.704 | -3.19 | -0.126 | 0.961 | -3.502 | 1.087 | 2.833 |
Other Information: | ||||||||||||||
Effect Of Forex Changes On Cash
| -0.072 | 0.015 | 0.303 | -0.146 | -0.121 | -0.066 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| 0.633 | -9.263 | 13.516 | -5.302 | -3.593 | -19.698 | -20.69 | 66.971 | -13.614 | 8.072 | 5.251 | 3.894 | 0.305 | 5.348 |
Cash At End Of Period
| 32.295 | 31.662 | 40.925 | 27.408 | 32.711 | 36.303 | 56.001 | 76.691 | 9.72 | 23.334 | 15.262 | 10.011 | 6.117 | 5.811 |